首页> 外文期刊>European urology >Predictive Factors for Ipsilateral Recurrence After Nephron-sparing Surgery in Renal Cell Carcinoma
【24h】

Predictive Factors for Ipsilateral Recurrence After Nephron-sparing Surgery in Renal Cell Carcinoma

机译:肾细胞癌的保肾手术后同侧复发的预测因素

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Ipsilateral recurrence after nephron-sparing surgery (NSS) is rare, and little is known about its specific determinants. Objective: To determine clinical or pathologic features associated with ipsilateral recurrence after NSS performed for renal cell carcinoma (RCC). Design, setting, and participants: We analysed 809 NSS procedures performed at eight academic institutions for sporadic RCCs retrospectively. Measurements: Age, gender, indication, tumour bilaterality, tumour size, tumour location, TNM stage, Fuhrman grade, histologic subtype, and presence of positive surgical margins (PSMs) were assessed as predictors for recurrence in univariate and multivariate analysis by using a Cox proportional hazards regression model. Results and limitations: Among 809 NSS procedures with a median follow-up of 27 (1-252) mo, 26 ipsilateral recurrences (3.2%) occurred at a median time of 27 (14.5-38.2) mo. In univariate analysis, the following variables were significantly associated with recurrence: pT3a stage k(p = 0.0489), imperative indication (p < 0.01), tumour bilaterality (p < 0.01), tumour size >4 cm (p < 0.01), Fuhrman grade III or IV (p = 0.0185), and PSM (p < 0.01). In multivariate analysis, tumour bilaterality, tumour size >4 cm, and presence of PSM remained independent predictive factors for RCC ipsilateral recurrence. Hazard ratios (HR) were 6.31, 4.57, and 11.5 for tumour bilaterality, tumour size >4 cm, and PSM status, respectively. The main limitations of this study included its retrospective nature and a short follow-up. Conclusions: RCC ipsilateral recurrence risk after NSS is significantly associated with tumour size >4 cm, tumour bilaterality (synchronous or asynchronous), and PSM. Careful follow-up should be advised in patients presenting with such characteristics.
机译:背景:保肾手术(NSS)后患侧复发很少见,对其具体决定因素了解甚少。目的:确定肾细胞癌(RCC)进行NSS后同侧复发相关的临床或病理特征。设计,设置和参与者:我们回顾性分析了八家学术机构针对零星RCC进行的809次NSS程序。测量:使用Cox评估年龄,性别,适应症,肿瘤双侧性,肿瘤大小,肿瘤位置,TNM分期,Fuhrman分级,组织学亚型和手术切缘阳性(PSM)的存在作为单因素和多因素分析复发的预测指标。比例风险回归模型。结果与局限性:在809例NSS手术中,中位随访时间为27(1-252)个月,其中26例同侧复发(3.2%)在中位时间为27个月(14.5-38.2)个月。在单变量分析中,以下变量与复发显着相关:pT3a期k(p = 0.0489),命令性指征(p <0.01),肿瘤双侧性(p <0.01),肿瘤大小> 4 cm(p <0.01),Fuhrman III或IV级(p = 0.0185)和PSM(p <0.01)。在多变量分析中,肿瘤的双边性,肿瘤大小> 4 cm和PSM的存在仍然是RCC同侧复发的独立预测因素。肿瘤的双侧性,肿瘤大小> 4 cm和PSM状态的危险比(HR)分别为6.31、4.57和11.5。这项研究的主要局限性包括其回顾性和短期随访。结论:NSS后RCC同侧复发风险与肿瘤大小> 4 cm,肿瘤双边性(同步或异步)和PSM显着相关。具有此类特征的患者应建议仔细随访。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号